SRX Global Provides Shareholders with Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO)

NORTH PALM BEACH, Fla., Sept. 24, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE American: SRXH) (the “Company” or “SRX”), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced an update to shareholders on the liquidation of portfolio holdings Vistagen Therapeutics (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company, and Greenland Mines (Nasdaq: GRML), a critical and precious minerals development company.

Additionally, the Company has added an investment in Onconetix Inc. (Nasdaq: ONCO). Onconetix has previously announced an agreement to acquire Realbotix LLC.